Mounjaro became India's top-selling drug in 2025, and a Scroll investigation reports that pharmacies are handing it out without the prescription it requires.
Recap by typeshit. Post by Scroll.in on X.
The Sunrise health expert says unregulated peptide use can put people in hospital, and in the worst cases leave them needing a new liver.
Some people on weight loss drugs are testing lower doses, hoping for fewer side effects. ThePrint reports on the trend, which these users describe themselves.
Bell raises the question of muscle loss for people losing weight on a GLP-1 and notes it isn't medical advice, pointing viewers to their doctor.
Dr. Woo points to the official position of the AAO and NANOS on whether routine eye exams just to check for NAION are needed.
The plastic surgeon weighs in on semaglutide and other GLP-1 drugs as more patients of every age turn to them for major weight loss.
A TV segment airing on WSIL and KFVS looks at the weight loss drug trend and what coverage people might be able to get through their insurance today.
Loading…